Matheus Fernandes de Oliveira

Matheus Fernandes de Oliveira

Auto-generated profile, based on publicly available information

Matheus Fernandes de Oliveira

DFV Neuro, Sao Paulo, Brazil

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2016 in Scientific Reports
Verified
Journal Article
Open access
JOJ. R. M Oliveira
J. R. M Oliveira
MOM. F Oliveira
M. F Oliveira
Brain calcification might be associated with various metabolic, infectious or vascular conditions. Clinically, brain calcification can include symptons such as migraine, parkinsonism, psychosis or dementia. The term Primary Brain Calcification was recently used for those patients without an obvious cause (formerly idiopathic) while Primary Familial Brain Calcifications was left for the cases with autosomal dominant inheritance. Recent studies found mutations in four genes (SLC20A2, PDGFRB, PDGFB and XPR1). However, these gene represent only 60% of all familial cases suggesting other genes remain to be elucidated. Studies evaluating treatments for such a devastating disease are scattered, usually appearing as single case reports. In the present study, we describe a case series of 7 patients treated with Alendronate, a widely prescribed biphosphanate. We observed good tolerance and evidence of improvements and stability by some patients. No side effects were reported and no specific symptoms related to medication. Younger patients and one individual continuing a prescription (prior to study commencement) appeared to respond more positively with some referred improvements in symptoms. Biphosphanates may represent an excellent prospect for the treatment of brain calcifications due to their being well tolerated and easily available. Conversely, prospective and controlled studies should promptly address weaknesses found in the present analysis.

1 June 2014 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
MOMatheus F. Oliveira
Matheus F. Oliveira
JOJoão R. M. Oliveira
João R. M. Oliveira
JRJosé M. Rotta
José M. Rotta
FPFernando C. G. Pinto
Fernando C. G. Pinto
Normal pressure hydrocephalus (NPH) is characterized by gait disturbance, dementia and/or urinary incontinence associated with dilation of ventricular system with normal opening cerebrospinal fluid pressure. Wide scientifical evidence confirms association between NPH and psychiatric symptoms. We selected 35 patients with idiopathic normal pressure hydrocephalus from January 2010 to January 2012 in a Brazilian tertiary hospital and performed a formal psychiatric evaluation to identify psychiatric disorders. Psychiatric disorders were present in 71% of these patients, especially anxiety, depression and psychotic syndromes. NPH patients may develop symptoms with frontal dominance, such as personality changes, anxiety, depression, psychotic syndromes, obsessive compulsive disorder, Othello syndrome; shoplifting and mania. Unusual appearances of NPH symptoms may hinder early diagnosis and consequently proper treatment.

9 March 2012 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
CFC. M. R. Franco
C. M. R. Franco
ALA. M. J. Lima
A. M. J. Lima
LAL. Ataíde
L. Ataíde
OLO. G. Lins
O. G. Lins
CCC. M. M. Castro
C. M. M. Castro
JOJ. R. M. Oliveira
J. R. M. Oliveira

1 April 2013 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
MOMatheus Fernandes de Oliveira
Matheus Fernandes de Oliveira
FSFelippe Saad
Felippe Saad
RRRodolfo Casimiro Reis
Rodolfo Casimiro Reis
JRJosé Marcus Rotta
José Marcus Rotta
FPFernando Campos Gomes Pinto
Fernando Campos Gomes Pinto
Idiopathic normal pressure hydrocephalus (iNPH) is characterized by gait disturbance, dementia and /or urinary incontinence, dilation of the ventricular system and normal opening cerebrospinal fluid pressure. Shunt surgery is the standard treatment of iNHP. Diversions with programmable valves are recommended, once drainage pressure can be changed. However, well-defined protocols still lack guiding the steps to attain proper pressure for each patient. Methods: In our study, we reported the experience of shunting 24 patients with iNPH using Strata® (Medtronic) valve, following a protocol based on a positive Tap Test. Results: We observed clinical improvement in 20 patients and stability/worsening in 4 patients. Complications occurred in five patients, including one death. The results display improvement, and complications occurred at a lower rate than reported in other studies. Conclusions: The Strata® valve used in the proposed protocol represents an efficient and safe tool in the treatment of iNPH.

13 April 2020 in Neurosurgical Review
Verified
Journal Article
Closed access
PDF file
LRLeonardo Gilmone Ruschel
Leonardo Gilmone Ruschel
GAGuilherme José Agnoletto
Guilherme José Agnoletto
AAAfonso Aragão
Afonso Aragão
JDJoel Sanabria Duarte
Joel Sanabria Duarte
MOMatheus Fernandes de Oliveira
Matheus Fernandes de Oliveira
ATAlisson R. Teles
Alisson R. Teles

1 September 2017 in World Neurosurgery
Verified
Journal Article
Closed access
GMGabriel André Silva Mendes
Gabriel André Silva Mendes
MOMatheus Fernandes de Oliveira
Matheus Fernandes de Oliveira
FPFernando Campos Gomes Pinto
Fernando Campos Gomes Pinto